Ads
related to: Liver and Cirrhosis Of The Liver
Search results
AKERO THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF...
Morningstar· 6 days agoClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 25, 2024 to file lead plaintiff applications in a securities class action lawsuit against Akero ...
7 Protein Deficiency Symptoms, According to Doctors — Best Life
Best Life· 1 day agoThere are six essential nutrients that your body simply cannot live without: carbohydrates, fats,...
Infected blood scandal: 'My dad suffered a vile death'
BBC News· 3 days agoGreg Murphy could not understand why his father Bill had been in such a rage when he told him he had...
Scientists May Have Discovered an Achilles Heel for Hepatitis B
SciTechDaily· 7 hours agoThe hepatitis B virus (HBV) is tiny, dangerous, and highly contagious. Most treatments try to inhibit the virus’s polymerase (pol) protein. Now researchers from the lab of Rockefeller’s Charles ...
AusperBio to Present AHB-137 Clinical Data Updates at EASL™ Congress 2024
The Yuma Sun· 20 hours ago– The company to present important new data from two Phase I trials of its leading molecule, AHB-137, aimed at achieving a functional cure for chronic hepatitis B, in two late-breaker posters ...
NHS health check could create 10-year map of major health risks, research finds
Daily Telegraph· 6 days agoThe current system focuses on cardiovascular risk, with patients recommended statins if their chance...
Beijing drug manufacturer aiming to develop liver fibrosis drug
China Daily· 6 days agoGyre Pharmaceuticals Co Ltd, also known as Beijing Continent, a Beijing-based innovative drug manufacturer for organ fibrosis, will deploy more resources to develop drugs related to liver fibrosis ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 4 days agoAKERO THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action ...
Doug Harvey: 100 Greatest NHL Players | NHL.com
NHL· 6 days agoIt was Harvey's seventh and final Norris Trophy. Harvey played one more year with the Rangers, and then was left unprotected in the 1963 intra-league...
Akero Therapeutics (AKRO) SYMMETRY Study Under Fire in Class Action – AKRO Investors with...
Morningstar· 6 days agoSAN FRANCISCO, May 23, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Akero Therapeutics, Inc. (NASDAQ: AKRO) investors who suffered substantial losses to submit their losses now. Class Period: Sep. 13, 2022 – Oct. 9, 2023Lead Plaintiff Deadline: June